Epstein Barr virus (EBV) - Cancer Research UK - Cancer news

Cancer Research UK launches trial to fight cancer caused by a common virus

Category: Press release
March 25, 2014
Cancer Research UK
Comments are closed
2 minute read

Cancer Research UK’s Drug Development Office (DDO) has launched a vaccine trial to treat some forms of cancer caused by the Epstein Barr Virus (EBV).

Developing a vaccine for the Epstein-Barr Virus could prevent up to 200,000 cancers globally say experts

Category: Press release
March 24, 2014
Cancer Research UK
Comments are closed
3 minute read

A vaccine to prevent infection with a common herpes virus, the Epstein-Barr Virus (EBV), could help prevent 200,000 new cancers worldwide per year.